Siegel RL, Miller KD, Wagle NS et al (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17–48. https://doi.org/10.3322/caac.21763

Article  PubMed  Google Scholar 

Rajkumar SV (2022) Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol 97(8):1086–1107. https://doi.org/10.1002/ajh.26590

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dimopoulos MA, Jakubowiak AJ, McCarthy PL et al (2020) Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma. Blood Cancer J 10(2):17. https://doi.org/10.1038/s41408-020-0273-x

Article  PubMed  PubMed Central  Google Scholar 

Xavier FD, Ferreira FSB, Abreu RM (2020) Treatment of elderly patients with refractory/relapsed multiple myeloma: oral drugs adherence and the COVID-19 outbreak. Oncotarget 11(47):4371. https://doi.org/10.18632/oncotarget.27819

Article  PubMed  PubMed Central  Google Scholar 

Solano M, Daguindau E, Faure C et al (2021) Oral therapy adherence and satisfaction in patients with multiple myeloma. Ann Hematol 100(7):1803–1813. https://doi.org/10.1007/S00277-021-04543-7

Elston Lafata J, Nguyen B, Staresinic C et al (2023) Interpersonal communication-, education- and counselling-based interventions to support adherence to oral anticancer therapy: a systematic review. J Oncol Pharm Pract 29(2):358–369. https://doi.org/10.1177/10781552211073576

Article  PubMed  Google Scholar 

Duncan M, Moschopoulou E, Herrington E et al (2017) Review of systematic reviews of non-pharmacological interventions to improve quality of life in cancer survivors. BMJ Open 7(11):e015860. https://doi.org/10.1136/bmjopen-2017-015860

Article  PubMed  PubMed Central  Google Scholar 

Halpin SN, Konomos M (2022) An iterative formative evaluation of medical education for multiple myeloma patients receiving autologous stem cell transplant. J Cancer Educ 37(3):779–787. https://doi.org/10.1007/s13187-020-01882-3

Article  PubMed  Google Scholar 

NCCN Guidelines for Patients Multiple myeloma. 2023

Google Scholar 

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Multiple Myeloma Version 3.2023 — December 8, 2022

Win KT, Roberts MRH, Oinas-Kukkonen H (2019) Persuasive system features in computer-mediated lifestyle modification interventions for physical activity. Inform. Health Soc Care 44(4):376–404. https://doi.org/10.1080/17538157.2018.1511565

Article  PubMed  Google Scholar 

Iyengar MS, Oinas-Kukkonen H, Win KT (2018) Persuasive technology in biomedical informatics. J Biomed Inform 85:136–137. https://doi.org/10.1016/j.jbi.2018.07.020

Article  PubMed  Google Scholar 

Lavsa SM, Holzworth A, Ansani NT (2003) Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc 51(1):90–94. https://doi.org/10.1331/JAPHA.2011.09154

Proskorovsky I, Lewis P, Williams CD et al (2014) Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma. Health Qual Life Outcomes 11(12):35. https://doi.org/10.1186/1477-7525-12-35

Article  Google Scholar 

Goerling U, Faller H, Hornemann B et al (2020) Information needs in cancer patients across the disease trajectory. A prospective study. Patient Educ Couns 103(1):120–126. https://doi.org/10.1016/j.pec.2019.08.011

Article  PubMed  Google Scholar 

World Health Organization (2003) Adherence to long- therm therapies. WHO

Google Scholar 

Palacios X, Vargas L (2011) Adherencia a la quimioterapia y radioterapia en pacientes oncológicos: una revisión de la literatura. Psicolonología 8(2–3):423–440. Available: https://revistas.ucm.es/index.php/PSIC/article/view/37890/36658

Google Scholar 

Kurtin S, Colson K, Tariman J et al (2016) Adherence, persistence and treatment fatigue in multiple myeloma. J Adv Pract Oncol 7(2). https://doi.org/10.6004/jadpro.2016.7.2.16

Kim H, Goldsmith JV, Sengupta S et al. Mobile health application and e-health literacy: opportunities and concerns for cancer patients and caregivers, J. Cancer Educ., vol. 34, no. 1, pp. 3–8, Feb. 2019. https://doi.org/10.1007/S13187-017-1293-5.

Clarke A, Paraskeva N, White P et al (2021) PEGASUS: the design of an intervention to facilitate shared decision-making in breast reconstruction. J Cancer Educ 36(3):508–518. https://doi.org/10.1007/s13187-019-01656-6

Article  CAS  PubMed  Google Scholar 

Moreau P, Zweegman S, Perrot A et al (2019) Evaluation of the prognostic value of positron emission tomography-computed tomography (PET-CT) at diagnosis and follow-up in transplant-eligible newly diagnosed multiple myeloma (TE NDMM) patients treated in the phase 3 cassiopeia study: Results of the CASSIOPET companion study. Blood 134(1):692. https://doi.org/10.1182/BLOOD-2019-123143

Article  Google Scholar 

Niesvizky R, Flinn IW, Rifkin R et al (2015) Community-based Phase IIIB trial of three UPFRONT bortezomib-based myeloma regimens. J Clin Oncol 33(33):3921–3929. https://doi.org/10.1200/JCO.2014.58.7618

Article  CAS  PubMed  Google Scholar